https://de.marketscreener.com/kurs/aktie/I-MAB-95388118/news/I-Mab-und-ABL-Bio-geben-jungste-Updates-des-PD-L1-und-4-1Bb-bispezifischen-Antikorpers-Tj-L14b-Abl-45033503/?utm_source=telegram&utm_medium=social&utm_campaign=share